Mersana Therapeutics, Inc. Operating Lease Liability
Mersana Therapeutics, Inc. had Operating Lease Liability of $5.15 million as of 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2025-03-03
- 2024-12-31: Operating Lease, Liability $5.15M.
- 2023-12-31: Operating Lease, Liability $8.40M.
- 2022-12-31: Operating Lease, Liability $11.37M.
- 2021-12-31: Operating Lease, Liability $13.55M.
| Period end | Operating Lease, Liability |
|---|---|
| 2024-12-31 | $5.15M 10-K · filed 2025-03-03 |
| 2023-12-31 | $8.40M 10-K · filed 2024-02-28 |
| 2022-12-31 | $11.37M 10-K · filed 2023-02-28 |
| 2021-12-31 | $13.55M 10-K · filed 2022-02-28 |
| 2021-09-30 | $14.14M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $14.72M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $11.30M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $11.59M 10-K · filed 2021-02-26 |
| 2020-09-30 | $11.89M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $12.17M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $12.45M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $2.90M 10-K · filed 2020-02-28 |
| 2019-09-30 | $3.67M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $4.25M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $4.84M 10-Q · filed 2019-05-09 |